Related Experiment Videos
ProBNP for stratifying patients with heart failure
Antonio Carlos Pereira-Barretto1, Mucio Tavares de Oliveira, Fabio Gazellato Franco
1Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Brazil. pereira.barretto@incor.usp.br
Arquivos Brasileiros De Cardiologia
|October 22, 2003
Summary
Serum N-Terminal ProBNP (ProBNP) levels accurately reflect heart failure (HF) severity. Elevated ProBNP, especially over 100 pmol/L, indicates decompensated HF and aids clinical assessment.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Management
Background:
- Clinical diagnosis of heart failure (HF) relies on clinical data, often lacking specificity.
- Complementary diagnostic tests for HF can have limitations in specificity.
Purpose of the Study:
- To determine if serum N-Terminal ProBNP (ProBNP) levels can accurately identify the clinical functional status of heart failure patients.
- To assess the utility of ProBNP as an auxiliary test in characterizing HF patients.
Main Methods:
- Sixty-nine patients with a history of HF were evaluated.
- Clinical, echocardiographic, and serum ProBNP levels were assessed.
- Patients were classified into functional classes (FC) I-IV based on clinical manifestations.
Main Results:
- ProBNP levels showed significant differences across functional classes (FC I < FC II < FC III).
- No correlation was found between ejection fraction (EF) and ProBNP levels.
- ProBNP values > 100 pmol/L identified decompensated HF with 98% sensitivity.
Conclusions:
- Serum ProBNP levels over 100 pmol/L are indicative of HF.
- Advanced HF patients typically present with ProBNP levels exceeding 270 pmol/L.
- ProBNP testing serves as an excellent auxiliary tool for the clinical characterization of HF.